Founded in 2005, Korea Institute for Pharmaceutical Policy Affairs, KIPPA, is a non-profit, public foundation, approved by the Korean Ministry of Health and Welfare. The institute is contributed by three relevant parties, the Korean Pharmaceutical Association (KPA), the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KBPMA), and the Korea Pharmaceutical Distribution Association (KPDA).

KIPPA is a leading research center, which aims to promote public health through the development of policy regarding the rational use of medicines, pharmacy education, pharmacy practice, pharmaceutical industry, and pharmaceutical supply and distribution. In particular, we begin to develop ¡®a community pharmacy model as a health promotion center for community members¡¯. We are collecting and analysing big data accordingly to develop pharmacy-based policies, which pursue maximised pharmacy practice for all the Koreans.

In consequence, KIPPA will consistently implement research tailored to the promotion of health in the nation and worldwide. We kindly ask for supports from our fellow pharmacists, public and associations.

If you have any further enquiries about the institute or research in English, please contact us via e-mail (kippa.org@gmail.com).

Thank you.

Office Address
3FL, 194, Hyoryeong-ro, Seocho-gu, Seoul, Repbulic of Korea

ÇöÀçÀ§Ä¡ : Home : ¾Ë¸²¸¶´ç : ¿¬±¸¼Ò ´º½º
   
¾Ë¸²¸¶´ç
°øÁö»çÇ×
º¸µµÀÚ·á
ÀÎÀçä¿ë
 
 
Á¦   ¸ñ [´ëÇѾà»çÀú³Î] °¨¿°Àü¹®¾à»ç ÇÁ·Î±×·¥ ¼±µÎ¡¦ÀÇ·áÁø°ú ÆÀÀÇ·á
³»   ¿ë

°¨¿°Àü¹®¾à»ç ÇÁ·Î±×·¥ ¼±µÎ¡¦ÀÇ·áÁø°ú ÆÀÀÇ·á

Ç×»ýÁ¦ ½ºÆ©¾îµå½Ê ÇÁ·Î±×·¥ ÇöȲ ¹× ¿î¿µ ¹æ¾È <2>


º» °í¿¡¼­´Â Áö³­ 2020³â 2¿ù ¹ß°£µÈ ¡®ÀǾàǰÁ¤Ã¥¿¬±¸¡¯ 14±Ç 2È£ [³í´Ü] ¿¡ ½Ç·È´ø <Ç×»ýÁ¦ ½ºÆ©¾îµå½Ê ÇÁ·Î±×·¥ ÇöȲ ¹× ¿î¿µ ¹æ¾È> ¿ø°í¸¦ ¿øÀúÀÚÀÇ ½ÂÀÎÀ» ¹Þ¾Æ, ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò ¸®Æ÷Æ® ÇмúÁö¸éÀ» ÅëÇØ Àç¼Ò°³ÇϰíÀÚ ÇÑ´Ù. ¡®ÀǾàǰÁ¤Ã¥¿¬±¸¡¯´Â ÀǾàǰ °³¹ß, »ý»ê, À¯Åë ¹× »ç¿ë°ú °ü·ÃµÈ Á¤Ã¥Àû À̽´¸¦ ±íÀÌ ÀÖ°Ô ¿¬±¸, ºÐ¼®ÇØ ÇÕ¸®ÀûÀΠÁ¤Ã¥À» Á¦½ÃÇϰíÀÚ 2006³â Ã¢°£µÈ ÀÌ·¡ ¿¬ 2ȸ ²ÙÁØÈ÷ ¹ßÇàµÇ°í Àִ Á¤±â°£Ç๰ÀÌ´Ù. [ÆíÁýÀÚ ÁÖ]


<Áö³­È£¿¡ À̾>
¥±. º»·Ð
2. Ç×»ýÁ¦ ½ºÆ©¾îµå½Ê ÇÁ·Î±×·¥ È¿°ú
Nathwani, et al.(2019) °¡ Ã¼°èÀû ¹®Çå°íÂû ¹æ¹ýÀ¸·Î 2017³â±îÁö ½ÃÇàµÈ 146°³ÀÇ Ç×»ýÁ¦ ½ºÆ©¾îµå½Ê ÇÁ·Î±×·¥ ¿î¿µ È¿°ú¿¡ ´ëÇÑ ¿¬±¸¸¦ ºÐ¼®ÇÑ °á°ú 85%ÀÇ ¿¬±¸¿¡¼­ Àç¿ø±â°£ °¨¼Ò, 92%ÀÇ ¿¬±¸¿¡¼­ Ç×»ýÁ¦ ºñ¿ë °¨¼Ò È¿°ú¸¦ º¸ÀΠ°ÍÀ¸·Î ³ªÅ¸³µ´Ù. 

ƯÈ÷ ¹Ì±¹ÀÇ ¿¬±¸µé¿¡¼­´Â È¯ÀÚ ÇÑ ¸í´ç 732´Þ·¯ÀÇ ºñ¿ë °¨¼Ò È¿°ú¸¦ º¸¿´°í, À̴ À¯·´ÀÇ ¿¬±¸µé¿¡¼­µµ À¯»çÇÑ °á°ú¿´´Ù<±×¸²1>.


John, et al.(1997) µîÀÇ ¿¬±¸¿¡ µû¸£¸é ºÎÀûÀýÇÑ Ç×»ýÁ¦ Ã³¹æÀ¸·Î ÀÎÇÑ °æÁ¦Àû ºÎ´ãÀº º´¿ø ¾àÁ¦ ºñ¿ëÀÇ 30%¿¡ ÇØ´çÇßÀ¸¸ç, Ç×»ýÁ¦ ½ºÆ©¾îµå½Ê ÇÁ·Î±×·¥ µµÀÔÀ¸·Î ¾àÁ¦ºñÀÇ 10~30%¸¦ °¨¼Ò½Ãų ¼ö Àִ °ÍÀ¸·Î Æò°¡µÆ´Ù.

Waters C.D.(2015)ÀÇ ¿¬±¸¿¡¼­ °¨¿°Àü¹®¾à»ç°¡ Ç×»ýÁ¦ ½ºÆ©¾îµå½Ê ÇÁ·Î±×·¥ÀÇ ¼±µÎ°¡ µÅ ´Ù¸¥ ÀÇ·áÁøµé°ú ÆÀ È¸Áø µîÀ» Çϸç È°µ¿ÇÑ °á°ú 33°³¿ù µ¿¾È 2457°ÇÀǠ󹿠ÁßÀ縦 Çß°í, Ã³¹æ ÁßÀç ¼ö¿ë·üÀº 91.8%¿´´Ù. 

¶ÇÇÑ ÀÌ·± È°µ¿À¸·Î ÀÎÇØ Áö¿ª»çȸ¼º Æó·ÅÀ¸·Î ÀÔ¿øÇѠȯÀÚÀÇ Àç¿ø±â°£À» Åë°èÀûÀ¸·Î À¯ÀÇÇϰԠ°¨¼Ò½Ã۰í, 2³â¿©µ¿¾È 35¸¸ 5000´Þ·¯(58%)ÀÇ ºñ¿ë Àý°¨ È¿°ú°¡ ÀÖ¾ú´Ù.

Fukuda, T. Niwa(2014) µîÀº ÀϺ»¿¡¼­ Ç×»ýÁ¦ ½ºÆ©¾îµå½Ê ÇÁ·Î±×·¥ ¾à»ç È°µ¿À» ÅëÇØ ÀûÀýÇÑ Ç×»ýÁ¦ »ç¿ë µµ¸ð, ºñ¿ë Àý°¨ È¿°ú, Àç¿ø±â°£ °¨¼Ò È¿°ú¸¦ º¸ÀΠ¿¬±¸¸¦ ¹ßÇ¥Çß´Ù.
 
ű¹ÀÇ Apisarnthanarak A.(2015)°¡ ¼öÇàÇÑ ¿¬±¸¿¡¼­´Â °¨¿° Àü¹®¾à»ç¸¦ ±³À° ÈÄ °¨¿°Àü¹®¾à»ç¿¡°Ô ÀÚ¹® ¾÷¹«¸¦ »õ·Î ¼öÇàÇØ ÀÚ¹®À» ¹ßÇàÇÑ ±º°ú ÀÚ¹®À» ½Ç½ÃÇÏÁö ¾ÊÀº ±ºÀ» ºñ±³ÇØ, ½Ç½Ã ±º¿¡¼­ ºÎÀûÀýÇÑ Ç×»ýÁ¦ÀÇ »ç¿ë, Àç¿ø±â°£ÀÌ Åë°èÀûÀ¸·Î À¯ÀÇÇϰԠ°¨¼ÒÇÑ °á°ú¸¦ º¸¿´´Ù.

3. Áֿ䠿ܱ¹ÀÇ Ç×»ýÁ¦ ½ºÆ©¾îµå½Ê ÇÁ·Î±×·¥ ¿î¿µÇöȲ
¼±Áø±¹¿¡¼­´Â À̹̠Ç×»ýÁ¦ ½ºÆ©¾îµå½Ê ÇÁ·Î±×·¥ÀÌ ¿î¿µµÇ°í ÀÖÀ¸¸ç, ¹Ì±¹, ¿µ±¹, EU, ÀϺ», È£ÁÖ¸¦ ºñ·ÔÇÑ ¿©·¯ ³ª¶ó¿¡¼­ Ç×»ýÁ¦ ½ºÆ©¾îµå½Ê µµÀÔ¿¡ ´ëÇÑ ÁöħÀ» Á¦½ÃÇϰí ÀÖ´Ù<Ç¥2>.


¾ÆÇÁ¸®Ä«, ¾Æ½Ã¾Æ, À¯·´, ºÏ¹Ì, ¿À¼¼¾Æ´Ï¾Æ, Áß³²¹ÌÀÇ 67°³ ±¹°¡¿¡¼­ Ç×»ýÁ¦ ½ºÆ©¾îµå½Ê ÇÁ·Î±×·¥ ÇöȲÀ» Æò°¡ÇØ º¸°íÇÑ ¹®Çå¿¡¼­ È®ÀεȠ»çÇ×Àº ´ÙÀ½°ú °°´Ù.

(1) Ç×»ýÁ¦ ½ºÆ©¾îµå½Ê ÇÁ·Î±×·¥ ½ÃÇà Áö¿ª
ÀÀ´äÇÑ ±¹°¡ÀÇ 52%¿¡¼­ ±¹°¡Àû Ç×»ýÁ¦ ½ºÆ©¾îµå½Ê ÇÁ·Î±×·¥ ±âÁØÀÌ Á¸ÀçÇßÀ¸¸ç, º´¿ø ±âÁØÀ¸·Î´Â 58%ÀÇ º´¿ø¿¡¼­ ±â°ü Ç×»ýÁ¦ ½ºÆ©¾îµå½Ê ÇÁ·Î±×·¥À» ½ÃÇàÇϰí ÀÖ¾úÀ¸¸ç ½ÃÇ࠱ⰣÀÇ Áß°£ °ªÀº 3³âÀ̾ú´Ù. 

À¯·´ ¹× ºÏ¹Ì´ë·ú¿¡¼­ Ç×»ýÁ¦ ½ºÆ©¾îµå½Ê ÇÁ·Î±×·¥ ½ÃÇà ºñÀ²ÀÌ 66~67%·Î °¡Àå ³ô°Ô º¸°íµÆÀ¸¸ç ¾ÆÇÁ¸®Ä«¿¡¼­ 14%·Î °¡Àå ³·°Ô º¸°íµÆ´Ù. 

±× ºóµµÀÇ Â÷À̴ ÀÖÀ¸³ª, Àü¼¼°èÀûÀ¸·Î Ç×»ýÁ¦ ½ºÆ©¾îµå½Ê ÇÁ·Î±×·¥ÀÌ µµÀԵнÃÇàµÇ°í ÀÖÀ½À» È®ÀÎÇÒ ¼ö ÀÖ¾ú´Ù. <´ÙÀ½È£¿¡ °è¼Ó>


[±â»çÃâó] https://www.kpanews.co.kr/academy/show.asp?page=1&search_cate=8&idx=499

 

¹øÈ£ ÷ºÎ Á¦¸ñ ÀÛ¼ºÀÚ ÀÛ¼ºÀÏ Á¶È¸
99 [´ëÇѾà»çÀú³Î] ó¹æ ÀûÁ¤¼º '°³¼±' ÀÌ»ó¹ÝÀÀ ¹ß»ý·ü '°¨¼Ò' ÀÌÁö¿¬ 2021-02-23 17
98 [´ëÇѾà»çÀú³Î] ÇØ¿Ü 85% º´¿ø, Ç×»ýÁ¦ »ç¿ë ¸ð´ÏÅ͸µ ½Ç½Ã ÀÌÁö¿¬ 2021-02-16 29
97 [´ëÇѾà»çÀú³Î] °¨¿°Àü¹®¾à»ç ÇÁ·Î±×·¥ ¼±µÎ¡¦ÀÇ·áÁø°ú ÆÀÀÇ·á ÀÌÁö¿¬ 2021-02-10 41
96 [¾à»ç°ø·Ð]´ÙÁ¦¾à¹° ÃÊÁ¡, 'Çѱ¹Çü Åð¿øÄɾºñ½º' ±¹Á¦¹«´ë¼­ 'ÁÖ¸ñ' ±è¼±Èñ 2021-02-04 57
95 [¸Þµð°ÔÀÌÆ®]ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò, FIP¿¡ Çѱ¹ Åð¿øÄɾºñ½º ¼Ò°³ ±è¼±Èñ 2021-02-04 54
94 [´ëÇѾà»çÀú³Î] Ç×»ýÁ¦ ½ºÆ©¾îµå½Ê ÇÁ·Î±×·¥ ÇöȲ ¹× ¿î¿µ ¹æ¾È ÀÌÁö¿¬ 2021-02-02 48
93 [´ëÇѾà»çÀú³Î] ȯÀÚ 'Æ÷°ýÀû ¾à¹° »ç¿ë °ü¸®' ÁÖ¿ä °ú¾÷ ÀÌÁö¿¬ 2021-01-26 64
92 [¸ÞµðÆÄ³ª´º½º]'Äڷγª19 ´ëÀÀ¡¤ÅëÇÕµ¹º½' ´Ù·é ÀǾàǰÁ¤Ã¥¿¬±¸ ¹ß°£ ±è¼±Èñ 2021-01-19 89
91 [¾à»ç°ø·Ð] ¾à±¹ °ÅÁ¡ Àڻ쿹¹æ»ç¾÷, »ý¸íÁöÅ´ÀÌ ¿ªÇÒ 'ÅåÅå' ±è¼±Èñ 2021-01-19 92
90 [µ¥Àϸ®ÆÊ] ÀϺ»¾à±¹ÀÇ ÁøÈ­¡¦Ä«µå·Î 'Áߺ¹Åõ¾à¡¤³²Àº ¾à °ü¸®±îÁö' ±è¼±Èñ 2021-01-19 85
89 [´ëÇѾà»çÀú³Î] ¼¼ÀÌÇÁ¾à±¹¡¤¹æ¹®¾à·á µî Ȱµ¿ Áö¼Ó Áõ°¡ ÀÌÁö¿¬ 2021-01-19 62
88 [´ëÇѾà»çÀú³Î] ¾à±¹ ó¹æÁýÁßµµ º¯È­¿Í ¾à±¹¾à»çÀÇ »çȸÀû ¿ªÇÒ Ãß±¸ ÀÌÁö¿¬ 2021-01-13 101
87 [´ëÇѾà»çÀú³Î] ÀåÁ¡Àº Ű¿ì°í ´ÜÁ¡Àº ¾ø¾Ö´Â ±³À°¹æ¹ýÀº? ÀÌÁö¿¬ 2021-01-06 134
86 [´ëÇѾà»çÀú³Î] 'Àڱ⠹ݿµ ¾ç½Ä' ÅëÇØ ¾à±¹ Àü¹®°¡ ±âÁØ ÆÄ¾Ç ÀÌÁö¿¬ 2020-12-29 136
85 [´ëÇѾà»çÀú³Î] CPD °³³ä µîÀå 80³â, ¿ì¸®³ª¶ó´Â ¾ÆÁ÷¡¦ ÀÌÁö¿¬ 2020-12-22 145

ÀÌÀü 10ÆäÀÌÁö [1]  [2]  [3]  [4]  [5]  [6]  [7]  ´ÙÀ½ 10ÆäÀÌÁö

 
 

¼­¿ï ¼­Ãʱ¸ È¿·É·Î194, 3Ãþ (Àç)ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò TEL : 02) 3474-5301 / FAX : 02)3474-5306

COPYRIGHT (C) 2006 KOREA INSTITUTE FOR PHARMACEUTICAL POLICY AFFAIRS ALL RIGHTS RESERVED. FOR MORE INFORMATION MAL kippa.org@gmail.com

±âºÎ±Ý ¾È³»